Gilead Sets Prices for COVID-19 Treatment Remdesivir
Publisher |
Media Type |
Categories Via RSS |
Health & Fitness
Publication Date |
Jun 30, 2020
Episode Duration |
The drug maker Gilead has set the price for remdesivir, its anti-viral drug which has been shown to be an effective treatment for COVID-19. For people on private insurance, it will cost $3,120 for a five day treatment. Gilead says that it could save hospitals about $12,000 per patient. Zachary Brennan, reporter at Politico, joins us for more on the costs of treating COVID-19. Learn more about your ad-choices at

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review